Utility of Fluorescence and Photoacoustic Imaging Intraoperatively to Assist With Robotic Assisted Minimally Invasive Surgery

This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • procedure : photoacoustic imaging
  • procedure : robot-assisted laparoscopic surgery
  • procedure : fluorescence imaging

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - 85 Years

Inclusion Criteria

- Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or kidney cancer based on previous biopsies or procedures OR a strong concern for a kidney malignancy based on computed tomography (CT) or magnetic resonance imaging (MRI) imaging - Ability to understand and the willingness to sign a written informed consent document

External Links

Stanford Medicine Resources:

Footer Links: